Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
Peer-reviewed publication validates efzofitimod’s unique anti-inflammatory mechanism of action on macrophages through neuropilin-2 (NRP2) ...
Plants survive cold by adjusting at cellular level. Scientists discovered that the PORCUPINE protein helps plants adapt to ...
President Donald Trump’s nominee for FDA Commissioner, Martin A. Makary, MD, sought to assure senators that if confirmed, he would support efforts to expedite reviews of new drugs indicted for rare ...
Ross McGinn ran the company Elev8 with Andrew Roberts, splicing electricity from the national grid to power a network of drug farms ...
This is the moment a gang posing as a legitimate company blew up a cable as they tried to splice electricity into an Albanian ...
McGinn, 33 and of Midway Road in Huyton, was sentenced to five years and four months, while Andrew Roberts, 42 and of Bell ...
As climate conditions become increasingly unpredictable, understanding how plants respond to cold is crucial for securing ...
The "Poverty, Prosperity, and Planet. Pathways Out of the Polycrisis" report evaluates progress towards these goals. It offers the first global assessment of poverty and shared prosperity ...
Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. President Donald Trump’s first month in office has been dizzying for U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results